Javascript must be enabled to continue!
TREATMENT OUTCOMES OF A COD LIVER OIL AND LANOLIN-BASED OINTMENT FOR MANAGING STAGE 1 AND 2 PRESSURE ULCERS IN OLDER PEOPLE
View through CrossRef
Objective: This study aimed to describe the evolution of pressure ulcers
(PU) in older patients treated with an ointment containing cod liver oil
and lanolin. Materials and Methods: A one-year prospective observational
study was conducted on patients with stage 1 and 2 PUs who were admitted
to an adult hospital. The ointment was applied once daily on the heels
or twice on the sacral areas. Data on age, sex, PU location, stage, and
risk assessment using the Braden scale were collected. The PUSH and
RESVECH scales were used to assess the PU evolution. Results: Twenty-six
patients with 35 PUs were included in this study. The treatment led to a
daily reduction of PUSH=0.89 and RESVECH=0.62 for sacral areas, and
PUSH=0.97 and RESVECH=0.77 for heel areas. While patients with diabetes
exhibited a slower rate of reduction in both PUSH and RESVECH scores
than non-diabetic patients, they still demonstrated a favorable
evolution with the treatment. In addition, the use of air mattresses
improved healing. Complete healing was achieved in 4 sacral cases, with
an average treatment duration of 6.00 ± 5.66 days for stage 1 and 7.5 ±
0.71 days for stage 2. Similarly, 12 heel PUs healed with an average
treatment duration of 7.63 ± 3.42 days for stage 1 and 13.25 ± 1.26 days
for stage 2. Conclusion: Our results suggest that cod liver oil and
lanolin-based ointment may be effective for treating stage 1 and 2 PUs
in older patients, with potential benefits, including faster healing
rates, particularly in conjunction with air mattress use.
Title: TREATMENT OUTCOMES OF A COD LIVER OIL AND LANOLIN-BASED OINTMENT FOR MANAGING STAGE 1 AND 2 PRESSURE ULCERS IN OLDER PEOPLE
Description:
Objective: This study aimed to describe the evolution of pressure ulcers
(PU) in older patients treated with an ointment containing cod liver oil
and lanolin.
Materials and Methods: A one-year prospective observational
study was conducted on patients with stage 1 and 2 PUs who were admitted
to an adult hospital.
The ointment was applied once daily on the heels
or twice on the sacral areas.
Data on age, sex, PU location, stage, and
risk assessment using the Braden scale were collected.
The PUSH and
RESVECH scales were used to assess the PU evolution.
Results: Twenty-six
patients with 35 PUs were included in this study.
The treatment led to a
daily reduction of PUSH=0.
89 and RESVECH=0.
62 for sacral areas, and
PUSH=0.
97 and RESVECH=0.
77 for heel areas.
While patients with diabetes
exhibited a slower rate of reduction in both PUSH and RESVECH scores
than non-diabetic patients, they still demonstrated a favorable
evolution with the treatment.
In addition, the use of air mattresses
improved healing.
Complete healing was achieved in 4 sacral cases, with
an average treatment duration of 6.
00 ± 5.
66 days for stage 1 and 7.
5 ±
0.
71 days for stage 2.
Similarly, 12 heel PUs healed with an average
treatment duration of 7.
63 ± 3.
42 days for stage 1 and 13.
25 ± 1.
26 days
for stage 2.
Conclusion: Our results suggest that cod liver oil and
lanolin-based ointment may be effective for treating stage 1 and 2 PUs
in older patients, with potential benefits, including faster healing
rates, particularly in conjunction with air mattress use.
Related Results
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Final Report of the Safety Assessment for PEG-75 Lanolin, PEG-20 Lanolin, PEG-27 Lanolin, PEG-30 Lanolin, PEG-40 Lanolin, PEG-50 Lanolin, PEG-60 Lanolin, and PEG-85 Lanolin
Final Report of the Safety Assessment for PEG-75 Lanolin, PEG-20 Lanolin, PEG-27 Lanolin, PEG-30 Lanolin, PEG-40 Lanolin, PEG-50 Lanolin, PEG-60 Lanolin, and PEG-85 Lanolin
PEG Lanolins are the polyethylene glycol ethers of whole lanolin. They are widely used in cosmetics as auxiliary oil/water emulsifiers at concentrations of up to 25%.
...
Study on anti-inflammatory and healing mechanism of Jiawei Shengji Yuhong ointment on wound based on NF-κBp65 / IL-1β / VEGF pathway
Study on anti-inflammatory and healing mechanism of Jiawei Shengji Yuhong ointment on wound based on NF-κBp65 / IL-1β / VEGF pathway
Abstract
Objective: To observe the effect of Jiawei Shengjiyuhong Ointment on wound repair of rat model after anal fistula surgery by regulating NF-κBp65 / IL-1β / VEGF sig...
Evaluation of the antimicrobial activity of propolis ointment against Staphylococcus aureus
Evaluation of the antimicrobial activity of propolis ointment against Staphylococcus aureus
Background: This study was carried out to determine the antimicrobial effect of propolis ointment formulations against Staphylococcus aureus.Methods: Propolis was extracted with 70...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

